Department of Surgery, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, NJ, USA.
J Gastric Cancer. 2012 Jun;12(2):55-62. doi: 10.5230/jgc.2012.12.2.55. Epub 2012 Jun 27.
There has been a large amount of speculation concerning the differences in the outcomes in patients who have gastric cancer in the Eastern and Western worlds. The differences in biology, surgical and adjuvant treatment have been used to explain such differences. There are clear differences observed in the histology (diffuse vs. intestinal), tumor location (proximal vs. distal), environmental exposures, dietary factors and Helicobacter pylori status. A higher incidence of gastric cancer in the East has led to screening programs, and leading to an earlier stage at presentation. Surgical treatment differs in that the extended lymph node dissection is routinely practiced in the Asian countries. Additionally, different adjuvant therapeutic regimens are used in both regions. The purpose of this review is to describe the differences in both presentation and treatment between the East and the West.
关于东方和西方世界的胃癌患者结局的差异,已经有大量的推测。生物学、手术和辅助治疗方面的差异被用来解释这些差异。在组织学(弥漫型与肠型)、肿瘤位置(近端与远端)、环境暴露、饮食因素和幽门螺杆菌状态方面观察到明显的差异。东方的胃癌发病率较高,导致了筛查计划的实施,并使患者在就诊时处于更早的阶段。手术治疗方面的差异在于,亚洲国家常规进行扩大淋巴结清扫。此外,两个地区使用的辅助治疗方案也不同。本文的目的是描述东方和西方在表现和治疗方面的差异。